Építés alatt – nem éles oldal
Belépés
LeállítvaNo phase

Metabolic Response to Food in Lung Cancer

Megadott ok: Poor accrual.

Key facts

Where
Baton Rouge, Egyesült ÁllamokSee the site

Where in Egyesült Államok

  • Pennington Biomedical Research CenterBaton Rouge, Egyesült ÁllamokNo longer taking part

Trial details

Who runs it
Pennington Biomedical Research Center
Trial code
NCT05937074
Record updated
2026. szeptember 17.
Original description
This goal of this study is to describe how unintentional weight loss influences fasting and post-prandial metabolic flexibility in participants with advanced non-small cell lung cancer.Read full original descriptionShow less

This goal of this study is to describe how unintentional weight loss influences fasting and post-prandial metabolic flexibility in participants with advanced non-small cell lung cancer.

Inclusion: Age greater than or equal to 18 years; Diagnosis of non-small-cell lung cancer; Reported weight stability or loss after cancer diagnosis; Body mass index less than or equal to 35 kilograms per meter squared; Ability to provide written informed consent; Willing and able to comply with all scheduled visits, treatment plans, lab tests, and other study procedure; Allow the collection and storage of biospecimens and data for future use.

Exclusion: Prior diagnosis of diabetes mellitus (type 1 or type 2); Any medications affecting gastric motility; Any other condition that, in the investigator's opinion, would preclude participation or successful compliance with the protocol; Currently pregnant or breastfeeding; Contraindication to consuming the liquid mixed meal.

ClinicalTrials.gov NCT05937074